查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572101

耳迷迷走神经刺激设备市场：按设备类型、应用、最终用户、分销管道划分 - 全球预测 2025-2030

Auricular Vagus Nerve Stimulation Devices Market by Device Type (External Devices, Implantable Devices), Application (Depression, Epilepsy, Pain Management), End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年耳迷迷走神经刺激设备市值为3.6987亿美元，预计2024年将达到3.9256亿美元，复合年增长率为5.94%，到2030年将达到5.5421亿美元，预计将达到1000万美元。

耳迷走神经刺激 (aVNS) 装置是神经调节疗法的重要进步，重点在于位于耳外的迷走神经。这些设备被定义为便携式、非侵入性设备，旨在刺激迷走神经的耳支，为许多健康状况提供治疗益处，包括癫痫、忧郁症和慢性疼痛。对 aVNS 设备的需求突出是因为它们有潜力提供一种非药物治疗选择，可以减轻药物相关的副作用。这些设备主要应用于医疗保健行业，特别是神经病学和精神病学，为医院、神经科学诊所和寻求家庭治疗的个别患者等最终用户提供服务。神经系统疾病的增加、对微创治疗的日益偏好以及监管部门批准的增加推动了市场成长。最新的商机在于扩大研究和开发，旨在使应用领域多样化，例如METABOLIC INC.症候群和压力相关疾病。为了抓住这些机会，公司应该专注于临床试验并与医疗保健提供者密切合作，以检验设备的功效和安全性。然而，市场扩张受到设备成本高、法律规范严格以及潜在用户和医疗保健专业人员认知度低等挑战的阻碍。 aVNS 设备的创新应旨在降低成本、增强用户介面并整合可穿戴技术，以提高设备的可访问性和便利性。此外，与高科技公司的合作可以透过整合人工智慧和机器学习来提供个人化的治疗方案，从而刺激创新。市场的快节奏需要持续监控并适应不断变化的法规和技术进步。位于医疗保健和技术交叉领域并专注于客製化患者照护解决方案的公司准备充分利用 aVNS 设备不断变化的需求。

主要市场统计
基准年[2023] 36987万美元
预测年份 [2024] 3.9256 亿美元
预测年份 [2030] 5.5421亿美元
复合年增长率（%） 5.94%

市场动态：快速发展的耳迷迷走神经刺激设备市场的关键市场洞察

耳迷迷走神经刺激设备市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 越来越多的慢性疾病需要有效的神经调节疗法
    • 加大医疗设备创新研发投入
    • 提高医疗保健专业人员和患者对神经刺激疗法的认识和接受度
    • 微创技术的进步促进迷走神经刺激设备的采用
  • 市场限制因素
    • 耳迷迷走神经刺激设备的高成本阻碍了市场渗透
  • 市场机会
    • 慢性疾病的盛行率不断增加，需要先进的耳迷走神经刺激解决方案
    • 人口老化的扩大推动了非药物疗法的采用，包括耳迷走神经刺激
    • 人们对心理健康意识的提高推动了对耳迷迷走神经刺激设备的需求
  • 市场挑战
    • 有限的临床证据影响医疗保健专业人员的可信度和可接受性

波特的五力：驾驭耳迷走迷走神经刺激设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解耳迷迷走神经刺激设备市场的外部影响

外部宏观环境因素在塑造耳迷迷走神经刺激设备市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解迷走神经刺激设备市场的竞争状况

对耳迷迷走神经刺激设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵耳迷迷走神经刺激设备市场供应商的绩效评估

FPNV 定位矩阵是评估耳迷迷走神经刺激设备市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了迷走神经刺激设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对耳迷走迷走神经刺激设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 越来越多的慢性疾病需要有效的神经调节疗法
      • 加大医疗设备创新研发投入
      • 医疗保健专业人员和患者对神经刺激疗法的认识和接受度正在提高
      • 微创技术的进步促进了迷走神经刺激设备的采用
    • 抑制因素
      • 耳迷迷走神经刺激设备的高成本阻碍了广泛的市场渗透
    • 机会
      • 越来越多的慢性疾病需要先进的耳迷走神经刺激解决方案
      • 随着人口老化的增加，诸如耳迷走神经刺激疗法等非药物治疗方法被引入。
      • 人们对心理健康的认识不断提高，推动了对耳迷迷走神经刺激设备的需求
    • 任务
      • 有限的临床证据影响医疗保健专业人员的可信度和接受度
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章耳迷迷走神经刺激设备市场（以设备类型）

  • 外部设备
    • 电极
    • 动力装置
  • 植入式装置
    • 生物感测器

第七章耳迷迷走神经刺激设备市场：依应用分类

  • 忧郁症
  • 癫痫
  • 疼痛管理
    • 慢性疼痛
    • 偏头痛
  • 耳鸣

第八章耳迷迷走神经刺激设备市场：依最终用户分类

  • 家庭护理设置
  • 医院
    • 住院病人
    • 门诊病人

第九章耳迷迷走神经刺激设备市场：按分销管道

  • 直销
  • 经销商
  • 网路零售

第10章美洲耳迷迷走神经刺激设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区耳迷迷走神经刺激设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲耳迷走迷走神经刺激设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-546E6FBB35F7

The Auricular Vagus Nerve Stimulation Devices Market was valued at USD 369.87 million in 2023, expected to reach USD 392.56 million in 2024, and is projected to grow at a CAGR of 5.94%, to USD 554.21 million by 2030.

Auricular Vagus Nerve Stimulation (aVNS) devices represent a significant advancement in neuromodulation therapies, focusing on the external vagus nerve located in the ear. These devices encompass a scope that includes definition as portable and non-invasive instruments designed to stimulate the auricular branch of the vagus nerve, providing therapeutic benefits for a multitude of health conditions like epilepsy, depression, and chronic pain. The necessity of aVNS devices is underscored by their potential to offer non-drug treatment alternatives that can reduce side effects associated with pharmaceuticals. These devices are predominantly applied in the healthcare industry, particularly in neurology and psychiatry, serving end-users such as hospitals, neurological clinics, and individual patients seeking home-based therapies. Market growth is powered by rising incidences of neurological disorders, escalating preference for minimally invasive treatments, and increasing regulatory approvals. The latest opportunities lie in expanding research and development efforts to diversify application areas, such as metabolic syndrome and stress-related ailments. To seize these opportunities, businesses should focus on clinical trials and strong collaborations with healthcare providers to validate device efficacy and safety. However, market expansion is hindered by challenges like high device costs, stringent regulatory frameworks, and a paucity of awareness among potential users and healthcare practitioners. Innovation in aVNS devices should target cost reduction, enhancing user interface, and integrating wearable technology to improve device accessibility and convenience. Moreover, partnerships with tech firms can spur innovation by integrating artificial intelligence and machine learning for personalized treatment options. The market's fast-paced nature demands continuous monitoring and adaptation to changing regulations and technological advancements. Businesses positioning themselves at the intersection of healthcare and technology, with an emphasis on customized patient care solutions, are poised to capitalize on the evolving demand for aVNS devices.

KEY MARKET STATISTICS
Base Year [2023] USD 369.87 million
Estimated Year [2024] USD 392.56 million
Forecast Year [2030] USD 554.21 million
CAGR (%) 5.94%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Auricular Vagus Nerve Stimulation Devices Market

The Auricular Vagus Nerve Stimulation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases requiring effective neuromodulation therapies
    • Growing investments in research and development for medical device innovation
    • Rising awareness and acceptance of neurostimulation therapies among healthcare professionals and patients
    • Advancements in minimally invasive techniques enhancing the adoption of vagus nerve stimulation devices
  • Market Restraints
    • High costs of auricular vagus nerve stimulation devices deterring widespread market penetration
  • Market Opportunities
    • Increasing prevalence of chronic diseases demanding advanced auricular vagus nerve stimulation solutions
    • Expanding aging population driving adoption of non-pharmacological therapies including auricular vagus nerve stimulation
    • Rising awareness about mental health pushing demand for auricular vagus nerve stimulation devices
  • Market Challenges
    • Limited clinical evidence affecting the credibility and acceptance among healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Auricular Vagus Nerve Stimulation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Auricular Vagus Nerve Stimulation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Auricular Vagus Nerve Stimulation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Auricular Vagus Nerve Stimulation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Auricular Vagus Nerve Stimulation Devices Market

A detailed market share analysis in the Auricular Vagus Nerve Stimulation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Auricular Vagus Nerve Stimulation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Auricular Vagus Nerve Stimulation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Auricular Vagus Nerve Stimulation Devices Market

A strategic analysis of the Auricular Vagus Nerve Stimulation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auricular Vagus Nerve Stimulation Devices Market, highlighting leading vendors and their innovative profiles. These include Bioness Inc., ElectroCore, Inc., LivaNova PLC, Medtronic plc, MicroTransponder Inc., Nervana LLC, NeuroPace, Inc., Neuros Medical, Inc., NeuroSigma, Inc., parasym Limited, ReShape Lifesciences Inc., SetPoint Medical, Soterix Medical Inc., and tVNS Technologies GmbH.

Market Segmentation & Coverage

This research report categorizes the Auricular Vagus Nerve Stimulation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across External Devices and Implantable Devices. The External Devices is further studied across Electrodes and Power Units. The Implantable Devices is further studied across Biosensors.
  • Based on Application, market is studied across Depression, Epilepsy, Pain Management, and Tinnitus. The Pain Management is further studied across Chronic Pain and Migraine.
  • Based on End User, market is studied across Homecare Settings and Hospitals. The Hospitals is further studied across In-Patient and Out-Patient.
  • Based on Distribution Channel, market is studied across Direct Sales, Distributors, and Online Retail.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases requiring effective neuromodulation therapies
      • 5.1.1.2. Growing investments in research and development for medical device innovation
      • 5.1.1.3. Rising awareness and acceptance of neurostimulation therapies among healthcare professionals and patients
      • 5.1.1.4. Advancements in minimally invasive techniques enhancing the adoption of vagus nerve stimulation devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of auricular vagus nerve stimulation devices deterring widespread market penetration
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing prevalence of chronic diseases demanding advanced auricular vagus nerve stimulation solutions
      • 5.1.3.2. Expanding aging population driving adoption of non-pharmacological therapies including auricular vagus nerve stimulation
      • 5.1.3.3. Rising awareness about mental health pushing demand for auricular vagus nerve stimulation devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited clinical evidence affecting the credibility and acceptance among healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Auricular Vagus Nerve Stimulation Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. External Devices
    • 6.2.1. Electrodes
    • 6.2.2. Power Units
  • 6.3. Implantable Devices
    • 6.3.1. Biosensors

7. Auricular Vagus Nerve Stimulation Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Depression
  • 7.3. Epilepsy
  • 7.4. Pain Management
    • 7.4.1. Chronic Pain
    • 7.4.2. Migraine
  • 7.5. Tinnitus

8. Auricular Vagus Nerve Stimulation Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Homecare Settings
  • 8.3. Hospitals
    • 8.3.1. In-Patient
    • 8.3.2. Out-Patient

9. Auricular Vagus Nerve Stimulation Devices Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Direct Sales
  • 9.3. Distributors
  • 9.4. Online Retail

10. Americas Auricular Vagus Nerve Stimulation Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Auricular Vagus Nerve Stimulation Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bioness Inc.
  • 2. ElectroCore, Inc.
  • 3. LivaNova PLC
  • 4. Medtronic plc
  • 5. MicroTransponder Inc.
  • 6. Nervana LLC
  • 7. NeuroPace, Inc.
  • 8. Neuros Medical, Inc.
  • 9. NeuroSigma, Inc.
  • 10. parasym Limited
  • 11. ReShape Lifesciences Inc.
  • 12. SetPoint Medical
  • 13. Soterix Medical Inc.
  • 14. tVNS Technologies GmbH

LIST OF FIGURES

  • FIGURE 1. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY ELECTRODES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY POWER UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY TINNITUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IN-PATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY OUT-PATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 197. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 240. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY EXTERNAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. POLAND AURICULAR VAGUS NERVE STIMULATION DEVICES MA